Biography

Originally from Texas, I earned a Bachelor’s in neuroscience and a concurrent Master’s in chemistry at Harvard, where I adopted a “cell to society” approach, combining medicine, law, and policy as instruments for advocacy across different scales of change. At Mass General Hospital and Harvard Medical School, I researched the development of a novel oncolytic virus to treat glioblastoma, an aggressive brain cancer. I have also conducted policy research on AI-equipped medical devices, brain-machine interfaces, and healthcare access for refugees, presenting findings to key government and private sector stakeholders. Pursuing an MPhil in Global Risk and Resilience at Cambridge, I aim to leverage my background in science and policy to develop frameworks for governing and de-risking emerging technologies at the intersection of the digital world and life sciences— a field called cyberbiosecurity. Ultimately, I aspire to advocate for patients on a broader scale, ensuring advances in biotechnology are safeguarded through responsible governance and resilient health systems. I am honored and excited to join the Gates Cambridge community.

Previous Education

Harvard University Neuroscience